Key facts
- It has raised $5.2M; the latest was Later Stage VC ($3.2M) in Aug 2025.
- Notable investors include Enterprise Ireland, Western Development Commission, Department of Enterprise, EIT Health, Furthr — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Galenband
- ·The full record, as it builds
Funding rounds
No funding rounds for Galenband are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Galenband
Developer of a wearable heart rhythm monitoring system designed to support proactive heart health management. The company offers continuous and convenient heart rhythm monitoring with advanced AI analysis to detect early indicators of silent atrial fibrillation, enabling individuals seeking proactive cardiac care to address potential concerns and pursue timely medical attention.
- Sector
- Healthcare
- HQ
- Galway City, Ireland
- Founded
- 2019
- Employees
- 12
- Website
- galenband.com/
- Ownership
- Privately Held (backing)
Galenband doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Galenband shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Galenband in its N-PORT filings yet. We sweep new filings monthly.